Archive · 19 Jul 2025
Hyderabad Centres Advance Genetic Research and Diagnostics
India is working hard to understand genetics.
Hyderabad is playing a big part, with research centers helping to study our genes.
They are working on projects to learn about our genes, diagnose diseases, and help families.
One project is studying the genes of many people across India to find out about genetic differences.
Others are focused on helping people with rare diseases.
They provide testing, training doctors, and financial support to make sure everyone has access to genetic care and treatments.
Hyderabad is becoming a key contributor to genetic education, tracing genetic disorders, and diagnostics in India.
Research institutes like CDFD, CCMB, and NIMS in Hyderabad are facilitating genome sequencing, patient identification, and therapeutic support.
Three major initiatives are underway with DBT funding: GenomeIndia, UMMID, and the Mission Program on Paediatric Rare Genetic Disorders (PRaGeD).
GenomeIndia has sequenced the genomes of 10,000 individuals, uncovering over 130 million genetic variants, many unique to Indian populations.
Under NPRD 2021, the Union health ministry aims to reduce rare diseases' burden with early detection and affordable care.
- Who
- CDFD, CCMB, NIMS, and other research institutes are involved.
- What
- Hyderabad research centers are contributing to genetic education, diagnostics, and treatment.
- When
- Initiatives are ongoing with DBT funding.
- Where
- Hyderabad, India
- Why
- To expand genetic education, trace genetic disorders, and provide diagnostics and therapeutic support.
Focus on Data and Discovery
Focus on Accessibility and Application
Project Goals
Focus on Data and Discovery
GenomeIndia focuses on data collection and discovery of genetic variations.
Focus on Accessibility and Application
UMMID aims to ensure the benefits of genetic science reach every corner of India.
- Key Institutes
- CDFD, CCMB, NIMS
- Projects
- GenomeIndia, UMMID, PRaGeD
- GenomeIndia Participants
- 10,000 individuals
- Genetic Variants Identified
- Over 130 million
- NIDAN Kendras Established
- 33 (in second phase)
- Financial Support (NPRD)
- Up to ₹50 lakh per patient
- Patients Receiving Funding
- 151